A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acticor Biotech SA
Accounts Payable Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Accounts Payable
€7.9m
CAGR 3-Years
34%
CAGR 5-Years
15%
CAGR 10-Years
3%
Valneva SE
PAR:VLA
Accounts Payable
€8.5m
CAGR 3-Years
-51%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
Nanobiotix SA
PAR:NANO
Accounts Payable
€173k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-19%
G
Genfit SA
PAR:GNFT
Accounts Payable
€22.2m
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
10%
Eurobio Scientific SA
PAR:ALERS
Accounts Payable
€13m
CAGR 3-Years
22%
CAGR 5-Years
32%
CAGR 10-Years
13%
OSE Immunotherapeutics SA
PAR:OSE
Accounts Payable
€8.3m
CAGR 3-Years
-14%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Accounts Payable?
Accounts Payable
7.9m EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Accounts Payable amounts to 7.9m EUR.

What is Acticor Biotech SA's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
3%

Over the last year, the Accounts Payable growth was 53%. The average annual Accounts Payable growth rates for Acticor Biotech SA have been 34% over the past three years , 15% over the past five years , and 3% over the past ten years .

Back to Top